Results 161 to 170 of about 9,911 (191)
Human medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 21, Status: Authorised
Case Medical Research, 2019 null nullsemanticscholar +4 more sourcesHuman medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 23, Status: Authorised
Case Medical Research, 2019 semanticscholar +3 more sourcesHuman medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of authorisation: 23/07/2007, Revision: 17, Status: Authorised
Case Medical Research, 2019 null nullsemanticscholar +3 more sourcesHuman medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 24/04/2008, Revision: 24, Status: Authorised
Case Medical Research, 2019 semanticscholar +3 more sourcesHuman medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of authorisation: 23/07/2007, Revision: 16, Status: Authorised
Case Medical Research, 2019 null nullcore +3 more sourcesHuman medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 24/04/2008, Revision: 23, Status: Authorised
Case Medical Research, 2019 null nullopenaire +2 more sourcesSome of the next articles are maybe not open access.Related searches: